• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
EC approves new Sarclisa indication PharmaTimes04:40 19-Apr-21
Sanofi launches Korea's 1st hexavalent vaccine Korea Biomedical Review01:57 19-Apr-21
In the last 7 days
Sanofi completes Kiadis acquisition Sanofi (Press Release)12:06 16-Apr-21
C4X Discovery and Sanofi ink €414m IL-17A blocker R&D contract European Biotechnology News07:09 13-Apr-21
Divided opinion PharmaTimes03:27 13-Apr-21
Sanofi declares the Offer for Kiadis unconditional GlobeNewswire (Press Release)01:05 13-Apr-21
In the last month
Sanofi Goes Big On Asia Vaccines With Singapore Investment Scrip Pharma Intelligence22:23 12-Apr-21
Sanofi Adds mRNA Specialist Tidal To Acquisition Spree Scrip Pharma Intelligence12:52 12-Apr-21
Sanofi confirm license agreement for C4XD oral IL-17A inhibitor programme InvestEgate (Company Announcements)10:32 12-Apr-21
Sanofi acquires mRNA specialist Tidal Therapeutics Manufacturing Chemist06:50 12-Apr-21
Sanofi acquires biotech company Tidal Therapeutics for $470m Pharmaceutical Technology06:49 12-Apr-21
Sanofi acquires Tidal Therapeutics Manufacturing Chemist05:49 12-Apr-21
Sanofi – Consensus Indicates Potential 29.4% Upside DirectorsTalk Interviews07:34 10-Apr-21
Sanofi completes Kymab acquisition Sanofi (Press Release)01:14 9-Apr-21
Sanofi Inks Agreement to Build Influenza Vaccine Manufacturing Facility in Canada Genetic Engineering and Biotechnology News10:16 5-Apr-21
Sanofi invests in influenza vaccine facility in Canada Manufacturing Chemist09:20 1-Apr-21
view more headlines
19 Apr 10:38

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.